simvastatin has been researched along with Hemorrhage in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 5 (55.56) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Chan, ECY; Soh, XQ; Tan, DS | 1 |
| Chen, XY; Chu, YT; Dong, Q; Hou, L; Li, CQ; Li, TT; Song, RS; Xia, B; Zhang, YY; Zhu, XY | 1 |
| Bosch, J; Iwakiri, Y | 1 |
| Felbor, U; Geisen, U; Heinz, J; Meckel, S; Reinhard, M; Schuchardt, F; Sure, U | 1 |
| Bormann, F; Czerny, C; Henrich, D; Höhn, C; Lehnert, M; Marzi, I; Relja, B; Seyboth, K | 1 |
| Azevedo, IM; Batista-Júnior, FF; Dantas, AC; Macedo, LF; Medeiros, AC; Mendes, MN | 1 |
| Altmann, P; Armitage, J; Baigent, C; Baxter, A; Cairns, HS; Collins, R; Foley, RN; Frighi, V; Kourellias, K; Landray, M; Leaper, C; Ratcliffe, PJ; Rogerson, M; Scoble, JE; Tomson, CR; Warwick, G; Wheeler, DC | 1 |
| Krane, V; Wanner, C | 1 |
| Ayer, R; Jadhav, V; Sugawara, T; Zhang, JH | 1 |
1 review(s) available for simvastatin and Hemorrhage
| Article | Year |
|---|---|
The portal hypertension syndrome: etiology, classification, relevance, and animal models.
Topics: Adrenergic beta-Antagonists; Animals; Ascites; Carcinoma, Hepatocellular; Early Detection of Cancer; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Healthy Lifestyle; Hemorrhage; Hepatic Encephalopathy; Hepatic Veins; Humans; Hypertension, Portal; Hypolipidemic Agents; Ligation; Liver Cirrhosis; Liver Neoplasms; Models, Animal; Prognosis; Simvastatin | 2018 |
1 trial(s) available for simvastatin and Hemorrhage
| Article | Year |
|---|---|
First United Kingdom Heart and Renal Protection (UK-HARP-I) study: biochemical efficacy and safety of simvastatin and safety of low-dose aspirin in chronic kidney disease.
Topics: Adult; Aged; Alanine Transaminase; Aspirin; Cardiovascular Diseases; Cholesterol, LDL; Chronic Disease; Creatine Kinase; Creatine Kinase, MM Form; Creatinine; Diabetic Nephropathies; Disease Progression; Feasibility Studies; Female; Hemorrhage; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Isoenzymes; Kidney Diseases; Kidney Transplantation; Lipids; Male; Middle Aged; Pilot Projects; Platelet Aggregation Inhibitors; Renal Dialysis; Renal Replacement Therapy; Simvastatin; Single-Blind Method; Thrombophilia; Treatment Outcome | 2005 |
7 other study(ies) available for simvastatin and Hemorrhage
| Article | Year |
|---|---|
Simvastatin, but Not Atorvastatin, Is Associated with Higher Peak Rivaroxaban Serum Levels and Bleeding: an Asian Cohort Study from Singapore.
Topics: Anticoagulants; Asian People; Atorvastatin; Atrial Fibrillation; Cohort Studies; Dabigatran; Drug Therapy, Combination; Hemorrhage; Humans; Rivaroxaban; Simvastatin; Singapore; Stroke | 2023 |
[Hemostatic Effect of Spleen-invigorating, Qi-replenishing and Blood-containing Formula on Simvastatin-induced Zebrafish Hemorrhage Model].
Topics: Animals; Disease Models, Animal; Drugs, Chinese Herbal; Hemorrhage; Hemostatics; Qi; Simvastatin; Spleen; Zebrafish | 2017 |
Authors' response to the letter by Dr. Eisa-Beygi.
Topics: Hemangioma, Cavernous, Central Nervous System; Hemorrhage; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Simvastatin | 2016 |
Simvastatin reduces mortality and hepatic injury after hemorrhage/resuscitation in rats.
Topics: Actins; Aldehydes; Animals; Apoptosis; Cytoskeleton; DNA Fragmentation; Hemodynamics; Hemorrhage; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Interleukin-6; Lipid Peroxidation; Liver; Male; Neutrophils; Nitric Oxide Synthase Type III; Rats; Resuscitation; Simvastatin; Tyrosine | 2010 |
Protective effect of simvastatin in the cyclophosphamide-induced hemorrhagic cystitis in rats.
Topics: Animals; Anti-Inflammatory Agents; Antineoplastic Agents, Alkylating; Cyclophosphamide; Cystitis; Cytokines; Disease Models, Animal; Hemorrhage; Male; Random Allocation; Rats; Rats, Wistar; Simvastatin; Urinary Tract | 2010 |
Statins and aspirin in chronic kidney disease: what does the UK-HARP-I trial tell us?
Topics: Aspirin; Cardiovascular Diseases; Cholesterol; Chronic Disease; Disease Progression; Hemorrhage; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney Diseases; Kidney Transplantation; Peritoneal Dialysis; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Renal Dialysis; Research Design; Simvastatin; Treatment Outcome | 2005 |
A new grading system evaluating bleeding scale in filament perforation subarachnoid hemorrhage rat model.
Topics: Analysis of Variance; Animals; Basilar Artery; Disease Models, Animal; Evaluation Studies as Topic; Hemorrhage; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Random Allocation; Rats; Rats, Sprague-Dawley; Severity of Illness Index; Simvastatin; Statistics as Topic; Subarachnoid Hemorrhage; Vasospasm, Intracranial | 2008 |